Product Information
CLOPIDOGREL 75 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0472 per EA under NDC 33342006010. Its NADAC has been published 604 times since Mar 11, 2015.
FDA first approved this application on Feb 10, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342006010
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLOPIDOGREL BISULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA202928FDA Approved
2/10/2014
TE Code
AB
On Market Since
10/16/2012
Pharmacological Classes
Price Statistics
The NADAC for CLOPIDOGREL 75 MG TABLET has been published 604 times since Mar 11, 2015, and over the history we have for it it has declined 51.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0472 per EA |
|---|---|
| All-time high | $0.1015 (Apr 15, 2015) |
| All-time low | $0.0469 (Jul 22, 2026) |
| 52-week high | $0.0563 |
| 52-week low | $0.0469 |
| Median price | $0.0643 |
| Average price | $0.0659 |
| Largest weekly change | -18.5% (Nov 20, 2024) |
| Weeks tracked | 604 |
| Tracking since | Mar 11, 2015 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clopidogrel market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
P2Y12 Platelet Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOPIDOGREL 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOPIDOGREL 75 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.0472 per EA (NDC 33342006010), effective Sep 30, 2026.
How has the price of CLOPIDOGREL 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOPIDOGREL 75 MG TABLET has declined 51.5%. It has been tracked across 604 weekly CMS publications since Mar 11, 2015.
What are the highest and lowest recorded NADAC prices for CLOPIDOGREL 75 MG TABLET?
Since Mar 11, 2015, the NADAC for CLOPIDOGREL 75 MG TABLET has ranged from a low of $0.0469 (Jul 22, 2026) to a high of $0.1015 (Apr 15, 2015), with a median of $0.0643 per EA.
Are there cheaper alternatives to CLOPIDOGREL 75 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLOPIDOGREL 75 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOPIDOGREL 75 MG TABLET?
CLOPIDOGREL 75 MG TABLET (NDC 33342006010) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.